https://www.selleckchem.com/pr....oducts/bms-986278.ht
An important challenge is how to combine these treatments to achieve the best control and minimise patients' neurological impairments, especially because of limited experience with the new target drugs, and the unknown toxicity of the different combinations. Future research should therefore focus on these areas in order to establish the best strategies for the treatment of brain metastases from non-small cell lung cancer. In this work, we intend to elucidate the best therapeutic options for patients diagnosed with brain metastases of
Like
Comment
Share
